IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#174
Positioning
Market Dominance
Manufacturing
Electronic Equipment
$969M
Issam Darwish
IHS Holding Limited owns, operates, and develops shared telecommunications infrastructure in Africa, Latin America, Europe, and the Middle East. It offers colocation and lease agreement, build-to-suit, fiber connectivity, and rural telephony solutions. The company was founded in 2001 and is based in London, the United Kingdom.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = IHS ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$IHS IHS Holding Ltd | 68 | 65 | 67 | 70 | - | 2.6x | -616.0% | -153.8% | 48.0% | 28.0% | -96.1% | -19.5% | 0.0% | 365.0x | $969M | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
IHS Holding Ltd (IHS) receives a "Buy" rating with a composite score of 67.5/100. It ranks #174 out of 7,333 stocks in our coverage universe and carries a 4-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Issam Darwish
Chief Executive Officer
Labor Force
2,290
65
57
69
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for IHS
Outperforming peers — winners tend to keep winning over 3-12 months
Trading at a discount to fundamentals — favorable entry valuation
High profitability & efficiency — strong quality floor supports entry
Low volatility — smoother ride and historically better risk-adjusted returns
Moderate investment profile
Top-rated overall — multiple factors aligned for strong entry
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for IHS.
View All RatingsImproving capital utilization rates confirmed
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 65 | 69 | -4NEUTRAL |
| MOMENTUM | 70 | 70 | 0NEUTRAL |
| VALUATION | 67 | 59 | +8ALPHA |
| INVESTMENT | 57 | 96 | -39DRAG |
| STABILITY | 69 | 64 | +5NEUTRAL |
| SHORT INT | 86 | 94 | -8DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC 11.4% vs WACC 29.4% (spread -18.0%)
GM 48% vs sector 43%, OM 28% vs sector 1%
Capital turnover 0.52x
Rev growth -19%, 4yr history
Interest coverage 0.2x, Net debt/EBITDA 5.9x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
IHS Holding Ltd receives a Buy rating with a composite score of 67.5/100 and 4 out of 5 stars, ranking #174 of 7,333 stocks in our universe. IHS displays a favorable combination of factors that positions it above the majority of the market. While not without risk, the quantitative profile supports a constructive outlook.
IHS earns a quality score of 65/100, indicating above-average business quality. The company reports a return on equity of -616.0% (sector avg: -2.5%), gross margins of 48.0% (sector avg: 42.5%), net margins of -96.1% (sector avg: -0.2%). Companies in this tier generally demonstrate consistent profitability and efficient capital deployment, though they may face some competitive pressure.
IHS's value score of 67/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include an EV/EBITDA of 2.65x, a P/B ratio of 2.52x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
With an investment score of 57/100, IHS exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of -19.5% vs. a sector average of 5.9% and a return on assets of -153.8% (sector: -0.1%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
IHS shows strong momentum characteristics with a score of 70/100. The stock has been trending above key moving averages, indicating solid demand from institutional buyers. Revenue growth stands at -19.5% year-over-year, while a beta of 0.81 reflects its sensitivity to broader market moves. This level of momentum typically signals sustained investor confidence and favorable near-term price action.
IHS shows good financial stability with a score of 69/100. Key stability metrics include a beta of 0.81 and a debt-to-equity ratio of 365.00x (sector avg: 0.2x). This suggests manageable leverage and moderate price volatility, making it appropriate for investors seeking a balance between growth potential and capital preservation.
IHS's short interest factor score of 86/100 indicates very low short selling activity relative to peers — a positive signal suggesting institutional investors see limited near-term downside. Specific risk factors include elevated leverage (D/E: 365.00x), small-cap liquidity risk. As a small-cap company with a market capitalization of $969M, IHS Holding Ltd benefits from the generally lower volatility and deeper liquidity associated with its size class.
IHS Holding Ltd is a small-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #174 of 7,333 overall (98th percentile). Key comparisons include ROE of -616.0% trailing the -2.5% sector median and operating margins of 28.0% above the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
Quant Factor Profile
Upgrade catalyst
Investment (57) is the limiting factor — improvement here would lift the composite score most.
EV/EBITDA 77% BELOW SECTOR MEDIAN (FAVORABLE)
ROE 24738% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 13% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF DEC 31, 2024 (Q3 FY2024)
We rate IHS Holding Ltd (IHS) as a Buy with a composite score of 67.5/100 at a current price of $7.99. The stock scores above average across the majority of our six quantitative factors and ranks #174 out of 7,333 stocks in our universe, reflecting a favorable risk-reward profile.
The rating is primarily driven by strength in momentum (70th percentile) and stability (69th percentile), which together account for the majority of the composite score. All factors score above the 40th percentile, indicating no material weakness in the quantitative profile. We assign a No Moat rating (35/100), High uncertainty, and Poor capital allocation.
Key items to watch: whether strong momentum is fundamentally supported by revenue trends; balance sheet deleveraging progress; the path to profitability. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
IHS Holding Ltd holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 67.5/100 places it at rank #174 in our full 7,333-stock universe. At $969M in market capitalization, IHS Holding Ltd is a small-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
Despite positive momentum (70th percentile), revenue contraction of -19% creates a divergence between price action and fundamental trajectory. This divergence suggests either that the market is looking through near-term weakness or that technical factors are temporarily inflating the stock. Investors should assess whether the revenue decline reflects cyclical weakness or structural challenges.
The margin cascade tells an important story: gross margins of 48% (+5.5pp vs sector) narrow to operating margins of 28% (+26.7pp vs sector) and net margins of -96.1%, yielding a gross-to-net conversion rate of -200%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $7.99, IHS Holding Ltd is trading near fair value based on current fundamentals. Our value factor score of 67/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. Valuation metrics are mixed, with no strong signal of mispricing in either direction.
The stock currently trades at EV/EBITDA of 2.6x (discounted to peers), P/B of 2.5x, P/S of 0.4x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
The stock's Buy rating (composite score 67.5/100) reflects broad-based quantitative strength, placing it in the top 20% of our 7,333-stock universe.
Gross margins of 48% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
A value factor score of 67/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
Positive momentum (70th percentile) indicates institutional accumulation and favorable technical dynamics that tend to persist in the intermediate term.
Elevated leverage (365% D/E) amplifies downside risk and limits management's financial flexibility in adverse scenarios.
Revenue decline of -19% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
We assign a High uncertainty rating to IHS Holding Ltd. Key risk factors include significant leverage (365% debt-to-equity), current negative profitability (net margin -96.1%), the combination of leverage (365% D/E) and thin margins (-96.1% net) amplifies downside risk. The wide range of potential outcomes widens our fair value estimate and increases the possibility of permanent capital impairment. Investors considering this name should size positions accordingly and demand a meaningful margin of safety before initiating.
Specific risk factors that inform our assessment include: significant leverage (365% debt-to-equity); current negative profitability (net margin -96.1%); the combination of leverage (365% D/E) and thin margins (-96.1% net) amplifies downside risk. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 69th percentile and quality factor at the 65th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 48% provide a buffer against cost pressures; above-average stability (69th percentile) suggests predictable business dynamics. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile warrants caution and disciplined position management.
We rate IHS Holding Ltd's capital allocation as Poor. Key concerns include low returns on equity (-616.0%), elevated leverage (365% D/E), negative profitability, weak asset returns (ROA -153.8%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — IHS Holding Ltd significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, IHS Holding Ltd receives a Buy rating with a composite score of 67.5/100 (rank #174 of 7,333). Our quantitative framework assigns a No Moat (35/100, trend: stable), High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 66/100.
Our analysis supports a constructive view on IHS Holding Ltd. The combination of the current valuation, high uncertainty, and poor capital allocation creates a risk-reward profile that favors accumulation at current levels. We recommend investors consider adding this name to portfolios aligned with the stock's risk profile.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign IHS Holding Ltd a meaningful economic moat, scoring 35/100 on our composite assessment. The ROIC-WACC spread of -18.0% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, margin superiority, reached only 16.7/20.
The strongest moat sources are margin superiority (16.7/20) and growth durability (9.4/20). GM 48% vs sector 43%, OM 28% vs sector 1%. Rev growth -19%, 4yr history. These pillars form the core of IHS Holding Ltd's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (0.1/20) and financial resilience (1/20). Capital turnover 0.52x. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect IHS Holding Ltd's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 48% providing a solid profitability foundation, operating margins of 28% reflecting effective cost management, declining revenues (-19%) that pressure the earnings outlook. The margin cascade from 48% gross to 28% operating to -96.1% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that the profit engine is high-quality and likely sustainable, with the quality factor at the 65th percentile.
The margin profile shows gross margins of 48%, operating margins of 28%, net margins of -96.1%. Return metrics include ROE of -616.0% and ROA of -153.8%. Relative to the Manufacturing sector, gross margins are 5.5 percentage points above the sector median of 43%, and ROE of -616.0% compares to a sector median of -2.5%.
The balance sheet reflects high leverage with D/E of 365%, which may limit financial flexibility, revenue growth of -19%. The sector median D/E is 0%, putting IHS Holding Ltd at higher leverage than the typical peer. Elevated leverage in combination with the current margin profile warrants close monitoring for any deterioration in debt-servicing capacity.
Thin net margins of -96.1% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
Elevated short interest (86th percentile) indicates that sophisticated market participants are betting against the stock.
Above 50MA
37.18%
Net New Highs
+51081

U.S. stock futures were flat on Tuesday as investors remained cautious ahead of the FOMC meeting. Analysts say the only certainty is that 'things will remain uncertain for the time being'.
IHS Holding (NYSE:IHS) has agreed to be acquired by MTN Group in an all cash transaction. The deal will take IHS private and is expected to result in its delisting from the NYSE. IHS is also exiting Latin America through the sale of its tower operations in the region to Macquarie Asset Management. These moves collectively reshape the company’s ownership structure, business model, and geographic footprint. IHS Holding runs telecom tower infrastructure, which is central to mobile connectivity...
LONDON & NEW YORK, February 17, 2026--IHS Holding Limited, (NYSE: IHS) ("IHS Towers" or the "Company"), one of the largest independent owners, operators and developers of shared communications infrastructure in the world by tower count, has today announced that it has entered into a merger agreement (the "Agreement") to be acquired by MTN Group Limited ("MTN"), a pan-African mobile operator, for $8.50 per ordinary share, in an all-cash transaction that values IHS Towers at an enterprise value of

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share. Westport Fuel Systems shares dipped 9.9% to $6.52 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Stoke Therapeutics, Inc. (NASDAQ: STOK) shares gained 72.6% to $11.24 after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome. C3is Inc. (NASDAQ: CISS) climbed 65% to $0.0581 after the company reported a year-over-year increase in fourth-quarter financial results. OpGen, Inc. (NASDAQ: OPGN) shares climbed 48.2% to $0.7039 after the company entered into a securities purchase agreement with a private investor, David Lazar, to acquire 3 million shares of Series E Convertible Preferred Stock at $1.00 per share for aggregate gross proceeds of $3.0 million. Mesoblast Limited (NASDAQ: MESO) gained 43.2% to $3.1501. Mesoblast was notified by the U.S. FDA that available clinical data from Phase 3 trial appear sufficient to support BLA submission for Remestemcel-L in children with steroid-refractory acute graft versus host disease. Praxis Precision Medicines Inc (NASDAQ: PRAX) gained 31.9% to $66.63 after the company reported results from a Phase 2a proof of concept study evaluating PRAX-628 in epilepsy patients with PPR. Nuvation Bio Inc (NYSE: NUVB) climbed 24.4% to $2.80 after BTIG upgraded the stock from Neutral to Buy. Check-Cap Ltd. (NASDAQ: CHEK) shares gained 24.3% to $2.40 after the company announced that it entered into a definitive Business Combination Agreement with Nobul AI. Viking Therapeutics ...

U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday. Shares of Tesla Inc (NASDAQ: TSLA) rose sharply during Tuesday’s session amid reports suggest Italy has approached the company about electric truck production. Multiple reports are highlighting new reporting from Italian news outlet Il Sole 24 Ore, suggesting Italy’s Industry Ministry officials have reached out to Tesla in regards to potentially manufacturing electric trucks in the country. Tesla shares surged 5.8% to $182.65 on Tuesday. Here are some other big stocks recording losses in today’s session. Praxis Precision Medicines Inc (NASDAQ: PRAX) shares jumped 31.9% to $66.63 after the company reported results from a Phase 2a proof of concept study evaluating PRAX-628 in epilepsy patients with PPR. Nuvation Bio Inc (NYSE: NUVB) surged 24.4% to $2.80 after BTIG upgraded the stock from Neutral to Buy. Krispy Kreme, Inc. ...